Radboud University Medical Center: COVID-19 trials

The registry lists 10 COVID-19 studies with Radboud University Medical Center as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 1 2Phase 2 2Phase 4 2No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety and Tolerability of COVID-19 Vaccine (ABNCoV2)CompletedNCT04839146Phase 1Results posted
• Intradermal Administration of a COVID-19 mRNA Vaccine in ElderlyTerminatedNCT05977127Phase 2
• CD8+ T-cell PET/CT Imaging in COVID-19 PatientsTerminatedNCT04874818
• Evaluation of Allied Healthcare in Patients Recovering From COVID-19Status unknownNCT04735744
• Mindful Prevention of Psychopathology in Healthcare Workers During the COVID-19 Crisis (COVID-19 MindPreP)CompletedNCT04720404Not applicable
• RGD PET/CT Imaging in COVID-19 PatientsCompletedNCT04596943
• Mucosal Immunity Against SARS-CoV-2 Infection in COVID-19 PatientsCompletedNCT04590352
• Lanadelumab for Treatment of COVID-19 DiseaseCompletedNCT04422509Phase 1/2
• Reducing COVID-19 Related Hospital Admission in Elderly by BCG VaccinationStatus unknownNCT04417335Phase 4
• Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection DiseaseTerminatedNCT04335786Phase 4